Novartis Investigative Site
Overland Park, Kansas 66210
We've found
6 trials
at this facility
Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 12/31/1969
Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 12/31/1969
Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure and Reduced Ejection Fraction Clinical Trial
Updated: 12/31/1969
Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Obesity Clinical Trial
Updated: 12/31/1969
Safety Study of LLF580 in Obese Volunteers
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials